Cellaviva Danmark October 23, 2020
Press release: ProTrans stem cells approved for clinical trials in COVID-19 patients

Press release: ProTrans stem cells approved for clinical trials in COVID-19 patients

Corona virus ProTrans for the treatment of patients with COVID-19 WED, OCT 21, 2020 17:00 CET NextCell Pharma AB ("NextCell") today announces that the application for clinical trial of COVID-19...

Cellaviva Danmark October 23, 2020
Allogeneic cell therapy has again shown an effect in type 1 diabetes

Allogeneic cell therapy has again shown an effect in type 1 diabetes

Type 1 diabetes ProTrans™, a drug candidate consisting of umbilical cord stem cells “Our vision is to improve treatment options for thousands, maybe millions of patients and reducing healthcare costs...

Cellaviva Danmark September 13, 2020
Rigshospitalet performs treatment with stem cells from the umbilical cord

Rigshospitalet performs treatment with stem cells from the umbilical cord

RIGSHOSPITALET Transplantation with stem cells from the umbilical cord is a treatment option for patients for whom we cannot find a suitable bone marrow donor. In Denmark, approx. 20% of...

Cellaviva Danmark September 8, 2020
Press release: ProTrans shows significant effect in Diabetes

Press release: ProTrans shows significant effect in Diabetes

Cellaviva's mother company NextCell Pharma AB ("NextCell") today announces that the ProTrans-2 clinical trial met the primary endpoint. Patients treated with a single dose ProTrans show a statistically significant improved...

Cellaviva Danmark May 11, 2020
Covid-19 study shows the positive effect of treatment with stem cells

Covid-19 study shows the positive effect of treatment with stem cells

The first study to test the effect of mesenchymal stem cells in the treatment of COVID-19 has now been published.

Cellaviva Danmark April 23, 2020
Covid-19 patients are treated with stem cells

Covid-19 patients are treated with stem cells

Covid-19 patients are treated with stem cells A study published in Aging and Disease* shows the effect of treatment with mesenchymal stem cells, MSC (the same type of stem cells...

Cellaviva Danmark April 9, 2020
Why you should consider storage from cord blood

Why you should consider storage from cord blood

The blood within your baby’s umbilical cord that remains in the umbilical cord and placenta after delivery, is called ‘cord blood’ for short. The umbilical cord contains the same powerful stem cells that help your baby develop organs, blood, tissue, and an immune system during pregnancy.

Cellaviva Danmark April 9, 2020
Why you should consider cord tissue storage

Why you should consider cord tissue storage

About cord tissue Mesenchymal stem cells, MSCs The difference between stem cells in cord tissue and cord blood It's important to note that umbilical cord blood and cord tissue are...